2-Methyl-2-sulfooctadecanoic acid

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 2-Methyl-2-sulfooctadecanoic acid
• 化学式: C₁₉H₃₈O₅S
• 分子量: 378.6
• InChiKey: WYHFUDMICVSSBD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7.2
• 重原子数：
  25
• 可旋转键数：
  17
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.95
• 拓扑面积：
  100
• 氢给体数：
  2
• 氢受体数：
  5

文献信息

• Capillary electrophoresis systems and additives
  申请人：——

  公开号：US20020162744A1

  公开（公告）日：2002-11-07

  Capillary electrophoresis systems, reagents, and processes for analyzing a sample which includes at least one protein constituent. The processes involve introducing the sample into a capillary tube containing a buffer system, wherein said buffer system includes at least one additive having an hydrophobic interaction with said at least one protein constituent and providing said at least one protein constituent with at least one negative charge thereby modifying the electrophoretic mobility

  毛细管电泳系统、试剂和工艺，用于分析包含至少一种蛋白质成分的样品。这些工艺包括将样品导入含有缓冲体系的毛细管中，其中所述缓冲体系包括至少一种添加剂，该添加剂与所述至少一种蛋白质成分具有疏水作用，并为所述至少一种蛋白质成分提供至少一种负电荷，从而改变电泳迁移率。
• Alkaline pH, free solution capillary electrophoresis method
  申请人：——

  公开号：US20020195341A1

  公开（公告）日：2002-12-26

  The invention concerns an alkaline pH, free solution capillary electrophoresis method for analysing clinical samples comprising protein constituents, characterized in that it comprises at least one step in which the sample is introduced into a capillary tube containing a buffer system comprising, as the buffer, a biological buffer with a pKa at 25° C. in the range 8.8 to 10.7 and at least one additive that can increase the ionic strength of the buffer system.

  本发明涉及一种用于分析含有蛋白质成分的临床样本的碱性 pH 值、自由溶液毛细管电泳方法，其特征在于该方法至少包括一个步骤，在该步骤中，将样本导入毛细管中，毛细管中含有缓冲体系，缓冲体系作为缓冲液，由生物缓冲液组成，生物缓冲液在 25 摄氏度时的 pKa 值在 8.8 至 10.7 之间，以及至少一种可增加缓冲体系离子强度的添加剂。
• SALTS OF PAROXETINE
  申请人：SMITHKLINE BEECHAM PLC

  公开号：EP1091958A1

  公开（公告）日：2001-04-18
• US7297244B2
  申请人：——

  公开号：US7297244B2

  公开（公告）日：2007-11-20
• [EN] SALTS OF PAROXETINE<br/>[FR] SELS DE PAROXETINE
  申请人：SMITHKLINE BEECHAM PLC

  公开号：WO2000001692A1

  公开（公告）日：2000-01-13

  Piperidine compounds, processes for preparing them, pharmaceutical compositions comprising them and their use in therapy are disclosed.